Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Disease on EC 3.4.24.B3 - matrix metalloproteinase-11

Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
DISEASE
TITLE OF PUBLICATION
LINK TO PUBMED
Adenocarcinoma
Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Extra- and Intracellular Imaging of human Matrix Metalloprotease 11 (hMMP-11) with a Cell-Penetrating FRET-Substrate.
Identification and Validation of an Individualized EMT-Related Prognostic Risk Score Formula in Gastric Adenocarcinoma Patients.
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Serum levels of MMP-11 correlate with clinical outcome in Chinese patients with advanced gastric adenocarcinoma.
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Adenocarcinoma of Lung
Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.
Secreted phosphoprotein 1 upstream invasive network construction and analysis of lung adenocarcinoma compared with human normal adjacent tissues by integrative biocomputation.
Adenoma
A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Aortic Aneurysm, Thoracic
Cellular phenotype transformation occurs during thoracic aortic aneurysm development.
Arthritis, Rheumatoid
Expression of stromelysin 3 and tissue inhibitors of matrix metallo-proteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis.
Astrocytoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Atherosclerosis
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Breast Diseases
Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases.
Breast Neoplasms
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
Analysis of potential markers for detection of submicroscopic lymph node metastases in breast cancer.
Assignment of the human stromelysin 3 (STMY3) gene to the q11.2 region of chromosome 22.
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Correlation between basic fibroblast growth factor immunostaining of stromal cells and stromelysin-3 mRNA expression in human breast carcinoma.
Correlation between stromelysin-3 mRNA level and outcome of human breast cancer.
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.
Diagnostic value of Doppler ultrasound parameters combined with MMP-11 in early breast cancer and benign breast diseases.
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
Evaluation of P1'-diversified phosphinic peptides leads to the development of highly selective inhibitors of MMP-11.
Expression of cathepsin D, stromelysin-3, and urokinase by reactive stromal cells on breast carcinoma prognosis.
Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlations.
Expression of stromelysin-3 and nm23 in breast carcinoma and related tissues.
Expression of UTX Indicates Poor Prognosis in Patients With Luminal Breast Cancer and is Associated With MMP-11 Expression.
Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ER? negative breast cancer cell lines.
Heterologous expression and functional characterization of matrix metalloproteinase-11 from canine mammary tumor.
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma.
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Isotopic labeling of terminal amines in complex samples identifies protein N-termini and protease cleavage products.
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Matrix metalloproteinase stromelysin-3 in development and pathogenesis.
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.
MMP11 expression in intratumoral inflammatory cells in breast cancer.
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein.
Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Prognostic significance of stromelysin 3, gelatinase A, and urokinase expression in breast cancer.
Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis.
Prospective-study of stromelysin-3 expression in breast-cancer biopsies and disease-free survival.
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion.
Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer.
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.
Stromelysin-3 expression by mammary tumor-associated fibroblasts under in vitro breast cancer cell induction.
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
The Association of Serum IL-33 and sST2 with Breast Cancer.
The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis.
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target]
[Stromal proteases in the progression of breast cancer]
Carcinogenesis
Altered gene expression in conjunctival squamous cell carcinoma.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Gastric cancer: basic aspects.
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
Prevention of colitis-associated carcinogenesis with infliximab.
Stromelysin-3 expression is an early event in human oral tumorigenesis.
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Carcinoid Tumor
Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Carcinoma
A comparative study of E-cadherin and stromelysin-3 expression in de novo and ex adenoma carcinoma of the colorectum.
Altered gene expression in conjunctival squamous cell carcinoma.
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Association of expression of metalloproteinases and their inhibitors with the metastatic potential of squamous-cell lung carcinomas. A molecular and immunohistochemical study.
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Characterization of monoclonal antibodies against stromelysin-3 and their use to evaluate stromelysin-3 levels in breast carcinoma by semi-quantitative immunohistochemistry.
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Dual regulation of stromelysin-3 by fibroblast growth factor-2 in murine osteoblasts.
E-cadherin, beta-catenin and stromelysin-3 expression in de novo carcinoma of the colorectum.
Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis.
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas.
Expression of stromelysin 3 in basal cell carcinomas.
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Expression of the stromelysin-3 gene in fibroblastic cells of invasive carcinomas of the breast and other human tissues: a review.
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
High levels of stromelysin-3 correlate with poor prognosis in patients with breast carcinoma.
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
Improved design of riboprobes from pBluescript and related vectors for in situ hybridization.
Increased expression of stromelysin-3 in basal cell carcinomas.
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Matrix-metalloproteinases in bronchopulmonary carcinomas.
Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas.
MMP-11 promoted the oral cancer migration and Fak/Src activation.
MMP11: a novel target antigen for cancer immunotherapy.
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Requirement for matrix metalloproteinase stromelysin-3 in cell migration and apoptosis during tissue remodeling in Xenopus laevis.
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Stromelysin 3: an independent prognostic factor for relapse-free survival in node-positive breast cancer and demonstration of novel breast carcinoma cell expression.
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Stromelysin-3 expression in early (pT1) carcinomas and pseudoinvasive lesions of the colorectum.
Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential.
Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Stromelysin-3 expression promotes tumor take in nude mice.
Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior.
Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Stromelysin-3: a paradigm for stroma-derived factors implicated in carcinoma progression.
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Substrate specificity of Xenopus matrix metalloproteinase stromelysin-3.
Transcriptional induction of stromelysin-3 in mesodermal cells is mediated by an upstream CCAAT/enhancer-binding protein element associated with a DNase I-hypersensitive site.
Transcriptional regulation of the Xenopus laevis Stromelysin-3 gene by thyroid hormone is mediated by a DNA element in the first intron.
Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
[Stromal proteases in the progression of breast cancer]
Carcinoma in Situ
Changes in the expression of matrix proteases and of the transcription factor c-Ets-1 during progression of precancerous bronchial lesions.
Carcinoma, Basal Cell
Breast-cancer-associated stromelysin-3 gene is expressed in basal cell carcinoma and during cutaneous wound healing.
Expression of stromelysin 3 in basal cell carcinomas.
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Increased expression of stromelysin-3 in basal cell carcinomas.
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Stromelysin-3: a potent marker for histopathologic differentiation between desmoplastic trichoepithelioma and morphealike basal cell carcinoma.
Carcinoma, Ductal
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma.
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Carcinoma, Hepatocellular
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
LINC00221 silencing prevents the progression of hepatocellular carcinoma through let-7a-5p-targeted inhibition of MMP11.
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
Carcinoma, Intraductal, Noninfiltrating
Comedo-ductal carcinoma in situ: A paradoxical role for programmed cell death.
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Carcinoma, Lobular
Matrix metalloproteinase-11 overexpressed in lobular carcinoma cells of the breast promotes anoikis resistance.
Carcinoma, Medullary
Expression of stromelysin-3 in medullary carcinoma of the breast.
Carcinoma, Non-Small-Cell Lung
Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Carcinoma, Renal Cell
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Carcinoma, Squamous Cell
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Increased expression of stromelysin-3 in basal cell carcinomas.
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
Cervical Intraepithelial Neoplasia
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Cholangiocarcinoma
High Expression of Matrix Metalloproteinase-11 indicates Poor Prognosis in Human Cholangiocarcinoma.
Colonic Neoplasms
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
Matrix-degrading metalloproteinases in tumor progression.
MMP11: a novel target antigen for cancer immunotherapy.
[Identification of protein markers for serum diagnosis of cancer based on microRNA expression profiling].
Colorectal Neoplasms
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Diagnostic values of MMP-7, MMP-9, MMP-11, TIMP-1, TIMP-2, CEA, and CA19-9 in patients with colorectal cancer.
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Neoplastic progression of human colorectal cancer is associated with overexpression of the stromelysin-3 and BM-40/SPARC genes.
Stromelysin-3 (ST-3) mRNA expression in colorectal carcinomas. Localization and clinicopathologic correlations.
Deafness
Fine genetic and comparative mapping of the deafness mutation Ames waltzer on mouse chromosome 10.
Dermatofibrosarcoma
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Diabetes Mellitus, Type 2
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Endometrial Hyperplasia
Significance of matrix metalloproteinase-7 [correction of matrix metalloproteinase-2], -11 and tissue inhibitor of metalloproteinase-1 expression in normal, hyperplastic and neoplastic endometrium.
Endometrial Neoplasms
Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.
Overexpression of the matrix metalloproteinase 11 gene is a potential biomarker for type 1 endometrial cancer.
Endometriosis
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Eutopic endometrium and peritoneal, ovarian and bowel endometriotic tissues express a different profile of matrix metalloproteinases-2, -3 and -11, and of tissue inhibitor metalloproteinases-1 and -2.
External validation of putative biomarkers in eutopic endometrium of women with endometriosis using NanoString technology.
Esophageal Neoplasms
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Esophageal Squamous Cell Carcinoma
Differential expression of MMP and uPA systems and prognostic relevance of their expression in esophageal squamous cell carcinoma.
Fibromatosis, Aggressive
Invasion and MMP expression profile in desmoid tumours.
Glioblastoma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Glioma
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Glomerulonephritis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Granulomatosis with Polyangiitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Hemangioma
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Histiocytoma, Benign Fibrous
Expression of MMP-2, MMP-9 and MMP-11 in dermatofibroma and dermatofibrosarcoma protuberans.
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Stromelysin 3 expression: a useful marker for the differential diagnosis dermatofibroma versus dermatofibrosarcoma protuberans.
Stromelysin-3 expression in the differential diagnosis of dermatofibroma and dermatofibrosarcoma protuberans: comparison with factor XIIIa and CD34.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Infertility
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Insulin Resistance
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance.
Intervertebral Disc Degeneration
Evaluation of the Association Between Matrix Metalloproteinase 11 and Intervertebral Disc Disease.
Laryngeal Neoplasms
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx.
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
Leiomyoma
Extracellular matrix remodeling and inflammatory pathway in human endometrium: insights from uterine leiomyomas.
Increased expression of stromelysin 3 mRNA in leiomyomas (uterine fibroids) compared with myometrium.
Leukemia
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Lung Neoplasms
Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.
Regulation of lung cancer cell growth and invasiveness by beta-TRCP.
Stromelysin-3 is overexpressed by stromal elements in primary non-small cell lung cancers and regulated by retinoic acid in pulmonary fibroblasts.
The Association of MMP-11 Promoter Polymorphisms With Susceptibility to Lung Cancer in Taiwan.
[Prognostic impact of matrix metalloproteinases 2,9, and 11 in stromal cells stage I non-small cell lung cancer]
Lymphatic Metastasis
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Corrigendum to "CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells" [Int. J. Biochem. Cell Biol. 39 (2007) 2135-2142].
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
MMP-11 promoted the oral cancer migration and Fak/Src activation.
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
Lymphoma
Expression of the metalloproteases MMP-1, MMP-2, MMP-3, MMP-9, MMP-11, TIMP-1 and TIMP-2 in angiocentric midfacial lymphomas.
matrix metalloproteinase-11 deficiency
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Melanoma
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Meningioma
Stromelysin-3 is expressed by aggressive meningiomas.
Metabolic Syndrome
Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Microscopic Polyangiitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.
Mouth Neoplasms
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Mucocutaneous Lymph Node Syndrome
Association between polymorphisms of matrix metalloproteinase 11 (MMP-11) and Kawasaki disease in the Korean population.
Nasal Polyps
Elevated S100A9 expression in chronic rhinosinusitis coincides with elevated MMP production and proliferation in vitro.
Neoplasm Metastasis
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
Cytokines related to MMP-11 expression by inflammatory cells and breast cancer metastasis.
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF.
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Expression and Clinical Significance of Metalloproteases and Their Inhibitors by Endothelial Cells From Invasive Breast Carcinomas.
Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features.
From a unique cell to metastasis is a long way to go: clues to stromelysin-3 participation.
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Gene Expression Profiling of Breast Cancer Brain Metastasis.
Gli1 enhances migration and invasion via up-regulation of MMP-11 and promotes metastasis in ER? negative breast cancer cell lines.
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
In vitro anti-metastatic activity of enterolactone, a mammalian lignan derived from flax lignan, and down-regulation of matrix metalloproteinases in MCF-7 and MDA MB 231 cell lines.
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
MMP-11 promoted the oral cancer migration and Fak/Src activation.
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis.
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
Stromelysin-3 gene expression in human cancer: an overview.
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
The paradoxical role of matrix metalloproteinase-11 in cancer.
The Role of Matrix Metalloproteinases in the Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma.
[Expression and clinical significance of stromelysin-3 in laryngeal cancer]
Neoplasm Micrometastasis
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
Neoplasms
A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas.
A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
A phenotype from tumor stroma based on the expression of metalloproteases and their inhibitors, associated with prognosis in breast cancer.
Additional MDA-MB-231 breast cancer cell matrix metalloproteinases promote invasiveness.
Altered gene expression in conjunctival squamous cell carcinoma.
Alternative splicing and promoter usage generates an intracellular stromelysin 3 isoform directly translated as an active matrix metalloproteinase.
Amplification of stromelysin-3 transcripts from carcinomas of the colon.
An assessment of MMP and TIMP gene expression in cell lines and stroma - tumour differences in microdissected breast cancer biopsies.
An exploratory study of host polymorphisms in genes that clinically characterize breast cancer tumors and pretreatment cognitive performance in breast cancer survivors.
Analysis of differences in the transcriptomic profiles of eutopic and ectopic endometriums in women with ovarian endometriosis.
Androgen-induced miR-135a acts as a tumor suppressor through downregulating RBAK and MMP11, and mediates resistance to androgen deprivation therapy.
Andrographolide induces DNA damage in prostate cancer cells.
Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.
Cancer-Associated Adipocytes Exhibit an Activated Phenotype and Contribute to Breast Cancer Invasion.
Cancer-associated fibroblasts affect breast cancer cell gene expression, invasion and angiogenesis.
CD147 depletion down-regulates matrix metalloproteinase-11, vascular endothelial growth factor-A expression and the lymphatic metastasis potential of murine hepatocarcinoma Hca-F cells.
Cellular localisation by in situ hybridisation of cathepsin D, stromelysin 3, and urokinase plasminogen activator RNAs in breast cancer.
Characterization of gene expression in major types of salivary gland carcinomas with epithelial differentiation.
Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases.
Circulating IgG response to stromelysin-3, collagenase-3, galectin-3 and mesothelin in patients with pharynx/larynx squamous cell carcinoma.
Circ_0000260 Regulates the Development and Deterioration of Gastric Adenocarcinoma with Cisplatin Resistance by Upregulating MMP11 via Targeting MiR-129-5p.
Clinicopathological significance of stromelysin-3 expression in colorectal cancer.
Coexpression of stromelysin-3 and insulin-like growth factor II in tumors of ectodermal, mesodermal, and endodermal origin: indicator of a fetal cell phenotype.
Comparative analysis of the expression patterns of metalloproteinases and their inhibitors in breast neoplasia, sporadic colorectal neoplasia, pulmonary carcinomas and malignant non-Hodgkin's lymphomas in humans.
Comparative study of the expression of metalloproteases and their inhibitors in different localizations within primary tumours and in metastatic lymph nodes of breast cancer.
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Demonstration in vivo that stromelysin-3 functions through its proteolytic activity.
Diagnostic and Prognostic Relevance of MMP-11 Expression in the Stromal Fibroblast-Like Cells Adjacent to Invasive Ductal Carcinoma of the Breast.
Differential expression of prognostic markers in histological subtypes of papillary renal cell carcinoma.
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.
Distribution of stromelysin-3 mRNA transcripts and microvessels in human breast carcinomas.
Dual stromelysin-3 function during natural mouse mammary tumor virus-ras tumor progression.
Elevated serum levels of MMP-11 correlate with poor prognosis in colon cancer patients.
Epithelial Mesenchymal Transition (EMT) in Metastatic Breast Cancer in Omani Women.
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Expression and prognostic significance of metalloproteinases and their tissue inhibitors in patients with small-cell lung cancer.
Expression and purification of human stromelysin 1 and 3 from baculovirus-infected insect cells.
Expression of CD147 mediates tumor cells invasion and multidrug resistance in hepatocellular carcinoma.
Expression of matrix metalloproteinases and their inhibitors correlates with invasion and metastasis in squamous cell carcinoma of the head and neck.
Expression of matrix metalloproteinases and their inhibitors in human bronchopulmonary carcinomas: quantificative and morphological analyses.
Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Expression of matrix metalloproteinases MMP-1, MMP-11 and MMP-19 is correlated with the WHO-grading of human malignant gliomas.
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response.
Expression of PACE4 in chemically induced carcinomas is associated with spindle cell tumor conversion and increased invasive ability.
Expression of stromelysin 3 in basal cell carcinomas.
Expression of stromelysin 3 in keratoarcanthoma and squamous cell carcinoma.
Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma.
Expression of stromelysin-3 (matrix metalloproteinase-11) in macrophages of murine thymus following thymocyte apoptosis.
Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo.
Expression of urokinase-type plasminogen activator, stromelysin 1, stromelysin 3, and matrilysin genes in lung carcinomas.
Expression of UTX Indicates Poor Prognosis in Patients With Luminal Breast Cancer and is Associated With MMP-11 Expression.
Expression pattern of metalloproteinases and their inhibitors changes with the progression of human sporadic colorectal neoplasia.
Extra- and Intracellular Imaging of human Matrix Metalloprotease 11 (hMMP-11) with a Cell-Penetrating FRET-Substrate.
Functional relationship between matrix metalloproteinase-11 and matrix metalloproteinase-14.
Furin inhibition results in absent or decreased invasiveness and tumorigenicity of human cancer cells.
Furin-dependent intracellular activation of the human stromelysin-3 zymogen.
Gastric cancer: basic aspects.
Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
Gene expression profile of normal and cancer-associated fibroblasts according to intratumoral inflammatory cells phenotype from breast cancer tissue.
Gene Expression Profiling of Breast Cancer Brain Metastasis.
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Heterologous expression and functional characterization of matrix metalloproteinase-11 from canine mammary tumor.
High cancer cell death in syngeneic tumors developed in host mice deficient for the stromelysin-3 matrix metalloproteinase.
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
High MMP-11 expression associated with low CD8+ T cells decreases the survival rate in patients with breast cancer.
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells.
HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Hydrolytic inactivation of a breast carcinoma cell-derived serpin by human stromelysin-3.
Identification of insulin-like growth factor-binding protein-1 as a potential physiological substrate for human stromelysin-3.
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer.
Identification of peptide substrates for human MMP-11 (stromelysin-3) using phage display.
Identification of structural determinants controlling human and mouse stromelysin-3 proteolytic activities.
Identification of the Prognosis-Related lncRNAs and Genes in Gastric Cancer.
Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer.
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma.
Impact of Matrix Metalloproteinases 11 Gene Variants on Urothelial Cell Carcinoma Development and Clinical Characteristics.
In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy.
Inflammation-related factors predicting prognosis of gastric cancer.
Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Integrative analysis with expanded DNA methylation data reveals common key regulators and pathways in cancers.
Invasion and MMP expression profile in desmoid tumours.
Joint Tumor Bud-MMP/TIMP Count at the Invasive Front Improves the Prognostic Evaluation of Invasive Breast Carcinoma.
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer.
Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts.
Localization by in situ hybridization of mRNAs encoding stromelysin 3 and tissue inhibitors of metallo-proteinases TIMP-1 and TIMP-2 in human head and neck carcinomas.
Lowered expression of microRNA-125a-5p in human hepatocellular carcinoma and up-regulation of its oncogenic targets sirtuin-7, matrix metalloproteinase-11, and c-Raf.
Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells.
Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
Matrix Metalloproteinase 11 Is a Potential Therapeutic Target in Lung Adenocarcinoma.
Matrix metalloproteinase 11 protects from diabesity and promotes metabolic switch.
Matrix metalloproteinase 11/stromelysin-3 exerts both activator and repressor functions during the hematogenous metastatic process in mice.
Matrix metalloproteinase expression is related to angiogenesis and histologic grade in spindle cell soft tissue neoplasms of the extremities.
Matrix metalloproteinase expression patterns in luminal A type breast carcinomas.
Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
Matrix Metalloproteinase-11 Gene Polymorphisms as a Risk for Hepatocellular Carcinoma Development in Egyptian Patients.
Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic Reprogramming and Increased IGF1/AKT/FoxO1 Signaling Pathway, Enhanced ER Stress and Alteration in Mitochondrial UPR.
Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions.
Matrix metalloproteinases-2,-3,-7,-9 and-10, but not MMP-11, are differentially expressed in normal, benign tumorigenic and malignant human keratinocyte cell lines.
Matrix-degrading metalloproteinases in tumor progression.
Matrix-metalloproteinases in bronchopulmonary carcinomas.
Metalloproteinase 11, potential marker and molecular target in advanced and castration-resistant prostate cancer. Culture study of peritumoral fibroblasts.
MicroRNA miR-24 Enhances Tumor Invasion and Metastasis by Targeting PTPN9 and PTPRF to Promote EGF Signaling.
MicroRNA miR-98 inhibits tumor angiogenesis and invasion by targeting activin receptor-like kinase-4 and matrix metalloproteinase-11.
MicroRNA-125b as a tumor suppressor by targeting MMP11 in breast cancer.
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.
MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues.
MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
MMP-11 as a biomarker for metastatic breast cancer by immunohistochemical-assisted imaging mass spectrometry.
MMP-11 promoted the oral cancer migration and Fak/Src activation.
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.
MMP11 promotes the proliferation and progression of breast cancer through stabilizing Smad2 protein.
MMP11: a novel target antigen for cancer immunotherapy.
Modulation of human stromelysin 3 promoter activity and gene expression by human breast cancer cells.
Molecular mechanisms governing microRNA-125a expression in human hepatocellular carcinoma cells.
mRNA expression of matrix metalloproteases and their inhibitors differs in subtypes of renal cell carcinomas.
Multimodal laser ablation/desorption imaging analysis of Zn and MMP-11 in breast tissues.
Mutual suppression of miR-125a and Lin28b in human hepatocellular carcinoma cells.
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.
New pathway links from cancer-progression determinants to gene expression of matrix metalloproteinases in breast cancer cells.
Norepinephrine inhibits migration and invasion of human glioblastoma cell cultures possibly via MMP-11 inhibition.
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
Overexpression of Matrix Metalloproteinase 11 in Thai Prostatic Adenocarcinoma is Associated with Poor Survival.
Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Production of a bioactive recombinant chicken matrix metalloproteinase-11 peptide in Escherichia coli.
Prognostic Influence of Tumor Stroma on Breast Cancer Subtypes.
Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
Prospective-study of stromelysin-3 expression in breast-cancer biopsies and disease-free survival.
Purification of active matrix metalloproteinase catalytic domains and its use for screening of specific stromelysin-3 inhibitors.
Reduced expression of collagen VI alpha 3 (COL6A3) confers resistance to inflammation-induced MCP1 expression in adipocytes.
Regulation of extracellular matrix remodeling and cell fate determination by matrix metalloproteinase stromelysin-3 during thyroid hormone-dependent post-embryonic development.
Regulatory mechanisms of miR-145 expression and the importance of its function in cancer metastasis.
Relationship between morphological features and kinetic patterns of enhancement of the dynamic breast magnetic resonance imaging and tumor expression of metalloproteases and their inhibitors in invasive breast cancer.
Relationship between the inflammatory molecular profile of breast carcinomas and distant metastasis development.
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Silencing CD147 inhibits tumor progression and increases chemosensitivity in murine lymphoid neoplasm P388D1 cells.
siRNA targeted against matrix metalloproteinase 11 inhibits the metastatic capability of murine hepatocarcinoma cell Hca-F to lymph nodes.
Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Stimulation of MMP-11 (stromelysin-3) expression in mouse fibroblasts by cytokines, collagen and co-culture with human breast cancer cell lines.
Stromal factors involved in human prostate cancer development, progression and castration resistance.
Stromal fibroblasts adjacent to invasive thyroid tumors: expression of gelatinase A but not stromelysin 3 mRNA.
Stromal matrix metalloproteinase-11 is involved in the mammary gland postnatal development.
Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression.
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines.
Stromelysin-3 (ST-3): immunohistochemical characterization of the matrix metalloproteinase (MMP)-11 in benign and malignant skin tumours and other skin disorders.
Stromelysin-3 and other stromelysins in breast cancer: importance of epithelial-stromal interactions during tumor progression.
Stromelysin-3 expression in breast cancer biopsies: clinico-pathological correlations.
Stromelysin-3 expression in invasive ovarian carcinomas and tumours of low malignant potential.
Stromelysin-3 expression in noninvasive and invasive neoplasms of the urinary bladder.
Stromelysin-3 expression is an early event in human oral tumorigenesis.
Stromelysin-3 expression promotes tumor take in nude mice.
Stromelysin-3 gene expression in human cancer: an overview.
Stromelysin-3 induction and interstitial collagenase repression by retinoic acid. Therapeutical implication of receptor-selective retinoids dissociating transactivation and AP-1-mediated transrepression.
Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front.
Stromelysin-3 is expressed by aggressive meningiomas.
Stromelysin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma.
Stromelysin-3 mRNA expression and malignancy: comparison with clinicopathological features and type IV collagenase mRNA expression in breast tumors.
Stromelysin-3 mRNA expression in dysplasias and invasive epithelial cancer of the larynx.
Stromelysin-3 protein expression in invasive breast cancer: relation to proliferation, cell survival and patients' outcome.
Stromelysin-3 suppresses tumor cell apoptosis in a murine model.
Study of matrix metalloproteinases and their inhibitors in prostate cancer.
The Association of Serum IL-33 and sST2 with Breast Cancer.
The clinical implications of MMP-11 and CK-20 expression in human breast cancer.
The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts.
The paradoxical role of matrix metalloproteinase-11 in cancer.
The proprotein convertases furin and PACE4 play a significant role in tumor progression.
Toll-Like Receptor 4 and Matrix Metalloproteases 11 and 13 as Predictors of Tumor Recurrence and Survival in Stage II Colorectal Cancer.
Tumor cell-mediated induction of the stromal factor stromelysin-3 requires heterotypic cell contact-dependent activation of specific protein kinase C isoforms.
Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients.
[Proteases by reactive stromal cells in cancer: an attractive therapeutic target]
[Roles of serine proteases and matrix metalloproteinases in tumor invasion and angiogenesis]
Obesity
Adipocyte hypertrophy in stromelysin-3 deficient mice with nutritionally induced obesity.
Cancer cells, adipocytes and matrix metalloproteinase 11: a vicious tumor progression cycle.
Cultured human peripheral blood mononuclear cells alter their gene expression when challenged with endocrine-disrupting chemicals.
Oligodendroglioma
Expression of MMP-2, MMP-7, MMP-9, MMP-10 and MMP-11 in human astrocytic and oligodendroglial gliomas.
Osteochondrodysplasias
Expression of Genes Encoding Extracellular Matrix Macromolecules and Metalloproteinases in Avian Tibial Dyschondroplasia.
Osteosarcoma
MicroRNA-192 inhibits the proliferation, migration and invasion of osteosarcoma cells and promotes apoptosis by targeting matrix metalloproteinase-11.
Ovarian Neoplasms
Evaluation of Matrix Metalloproteinases, Cytokines and Their Potential Role in the Development of Ovarian Cancer.
Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer.
Pancreatic Neoplasms
Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival.
Identification of Matrix Metalloproteinase 11 as a Prognostic Biomarker in Pancreatic Cancer.
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Matrix Metalloproteinase 11 as a Novel Tumor Promoter and Diagnostic and Prognostic Biomarker for Pancreatic Ductal Adenocarcinoma.
Smad-Sp1 complexes mediate TGFbeta-induced early transcription of oncogenic Smad7 in pancreatic cancer cells.
Stromelysin 3 is overexpressed in human pancreatic carcinoma and regulated by retinoic acid in pancreatic carcinoma cell lines.
Papillomavirus Infections
Co-expression of metalloproteinases 11 and 12 in cervical scrapes cells from cervical precursor lesions.
Prostatic Neoplasms
Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients.
Correlation between Microvascular Density and Matrix Metalloproteinase 11 Expression in Prostate Cancer Tissues: a Preliminary Study in Thailand.
Impact of Matrix Metalloproteinase-11 Gene Polymorphisms on Biochemical Recurrence and Clinicopathological Characteristics of Prostate Cancer.
Skin Neoplasms
HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer.
Squamous Cell Carcinoma of Head and Neck
Association of matrix metalloproteinase-11 polymorphisms with susceptibility and clinicopathologic characteristics for oral squamous cell carcinoma.
High level of plasma matrix metalloproteinase-11 is associated with clinicopathological characteristics in patients with oral squamous cell carcinoma.
Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas.
MMP-11 promoted the oral cancer migration and Fak/Src activation.
Significance of MMP11 and P14(ARF) expressions in clinical outcomes of patients with laryngeal cancer.
Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
Stomach Neoplasms
Cellular prion protein promotes invasion and metastasis of gastric cancer.
Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Identification of matrix metalloproteinase 11 as a predictive tumor marker in serum based on gene expression profiling.
IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1/STAT3 signaling pathway.
Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review).
Knockdown of MMP11 inhibits proliferation and invasion of gastric cancer cells.
LncRNA CTBP1-AS2 Facilitates Gastric Cancer Progression via Regulating the miR-139-3p/MMP11 Axis.
Matrix metalloproteinase 11 depletion inhibits cell proliferation in gastric cancer cells.
Matrix metalloproteinase gene expressions might be oxidative stress targets in gastric cancer cell lines.
Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
UBE2C Is a Potential Biomarker of Intestinal-Type Gastric Cancer With Chromosomal Instability.
Synovitis
Expression of stromelysin 3 and tissue inhibitors of matrix metallo-proteinases, TIMP-1 and TIMP-2, in rheumatoid arthritis.
Tendinopathy
Epigenetic Status of The Human MMP11 Gene Promoter is Altered in Patellar Tendinopathy.
Thromboangiitis Obliterans
Increased serum HMGB-1, ICAM-1 and Metalloproteinase-9 levels in Buerger's patients.
Thrombosis
Expression changes and roles of matrix metalloproteinases in a rat model of traumatic deep vein thrombosis.
Thyroid Cancer, Papillary
Hepatocyte growth factor receptor, matrix metalloproteinase-11, tissue inhibitor of metalloproteinase-1, and fibronectin are up-regulated in papillary thyroid carcinoma: a cDNA and tissue microarray study.
Inverse relationships between the expression of MMP-7 and MMP-11 and predictors of poor prognosis of papillary thyroid carcinoma.
miR-125a-3p suppresses the growth and progression of papillary thyroid carcinoma cell by targeting MMP11.
[Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer.]
Thyroid Neoplasms
MMP-11 promotes papillary thyroid cell proliferation and invasion via the NF-?B pathway.
[Gene expression of metalloproteinase 11, claudin 1 and selected adhesion related genes in papillary thyroid cancer.]
Triple Negative Breast Neoplasms
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple-negative breast cancer.
Urinary Bladder Neoplasms
Matrix Metalloproteinase 11 is a Potential Biomarker in Bladder Cancer Diagnosis and Prognosis.
Promoter analysis of epigenetically controlled genes in bladder cancer.
Usher Syndromes
Fine genetic and comparative mapping of the deafness mutation Ames waltzer on mouse chromosome 10.
Uterine Cervical Neoplasms
Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
[The utility of metalloproteinases (MMPs) and their inhibitors (TIMPs) in diagnostics of gynecological malignancies].
Vascular Malformations
Markers of vascular differentiation, proliferation and tissue remodeling in juvenile nasopharyngeal angiofibromas.
Vascular System Injuries
Accelerated neointima formation after vascular injury in mice with stromelysin-3 (MMP-11) gene inactivation.
Vasculitis
The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis.